Hitoshi Kawazoe

Peripheral blood biomarkers predict immune-related adverse events in non-small cell lung cancer patients treated with pembrolizumab: a multicenter retrospective study

Saeka Egami, Hitoshi Kawazoe, Hironobu Hashimoto et al. · Journal of Cancer · 2021 · 50 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A Nationwide, Multicenter Registry Study of Antiemesis for Carboplatin-Based Chemotherapy-Induced Nausea and Vomiting in Japan

Hirotoshi Iihara, Mototsugu Shimokawa, Toshinobu Hayashi et al. · The Oncologist · 2019 · 35 citations · Full text

Medicine, Oncology, Pharmacology +13

Change of the Blood Concentration of Tacrolimus after the Switch from Fluconazole to Voriconazole in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Hitoshi Kawazoe, Yoshiharu Takiguchi, Hiroaki Tanaka et al. · Biological and Pharmaceutical Bulletin · 2006 · 28 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Absolute Lymphocyte Count Predicts Immune-Related Adverse Events in Patients With Non-Small-Cell Lung Cancer Treated With Nivolumab Monotherapy: A Multicenter Retrospective Study

Saeka Egami, Hitoshi Kawazoe, Hironobu Hashimoto et al. · Frontiers in Oncology · 2021 · 28 citations · Full text

Medicine, Immunology, Oncology +16

Patient-related Risk Factors for Nausea and Vomiting with Standard Antiemetics in Patients with Breast Cancer Receiving Anthracycline-based Chemotherapy: A Retrospective Observational Study

Hitoshi Kawazoe, Akari Murakami, Michiko Yamashita et al. · Clinical Therapeutics · 2018 · 26 citations

Medicine, Oncology, Pharmacotherapy +17